Bicara Therapeutics Plans $200 Million IPO For Head & Neck Cancer Drug Seeking Alpha Bicara Therapeutics Plans $200 Million IPO For Head & Neck Cancer Drug. IPOs 3 weeks
Bajaj Housing Finance Shares Surge After India’s Biggest IPO This Year The Wall Street Journal 15 hours
If You Had Invested $1,000 in Qualcomm Stock 33 Years Ago, Here’s How Much You Would Have Today The Motley Fool 1 day
China’s Midea to Raise $4 Billion in Hong Kong’s Biggest Listing This Year The Wall Street Journal 4 days
If You Bought 1 Share of AMD at Its IPO, Here’s How Many Shares You Would Own Now The Motley Fool 4 days
One of Wall Street’s Highest-Flying Stocks — a Nearly 125,000%-Gainer Since Its IPO — Has Officially Completed Its Latest Stock Split The Motley Fool 4 days
If You Bought 1 Share of Broadcom at Its IPO, Here’s How Many Shares You Would Own Now The Motley Fool 6 days
Exclusive-Data center operator Switch weighs IPO at about $40 billion valuation, sources say Investing.com 6 days
Meta Platforms Acting Like A Young Growth Stock: See New Names On IBD 50, Stock Spotlight And More Investor's Business Daily 7 days
U.S. IPO Weekly Recap: 2 APAC Microcaps Go Public In Short Labor Day Week As The Pipeline Grows Seeking Alpha 1 week
If You’d Invested $1,000 in Lyft Stock 3 Years Ago, Here’s How Much You’d Have Today The Motley Fool 2 weeks